Abstract
Aim:
Breviscapine isolated from the Chinese herb Erigeron breviscapus (Vant) Hand-Mazz is widely used to treat cardiovascular and cerebrovascular diseases. The aim of this study was to improve the pharmacokinetic profiles of breviscapine using nanostructured lipid carrier based on an ionic complex formation.
Methods:
Breviscapine nanostructured lipid carrier (Bre-NLC) was prepared using the thin film homogenization method. The morphology of Bre-NLCs was determined using transmission electron microscopy. The mean particle size, polydispersity index, zeta-potential analysis and entrapment efficiency were analized. In vitro release was studied using the dialysis method. In vitro stability was studied in fresh plasma and liver slurry of rats. In vivo pharmacokinetics was analyzed in rats after intravenous injection of a dose equivalent to breviscapine (10 mg/kg).
Results:
The Bre-NLCs were spherical with a mean particle size of ∼170 nm, a zeta potential of ∼20 mV and a high entrapment efficiency of ∼89%. Compared with a commercially available solution, a substantial decrease in the cumulative release of breviscapine was found for the Bre-NLCs. The NLC has a significantly protective effect against the liver enzyme degradation of breviscapine. After intravenous administration in rats, the Bre-NLCs exhibited a 32 times increase in the AUC0–t and a 12 times increase in T1/2 as compared to the commercially available breviscapine solution.
Conclusion:
The results demonstrate that the NLC has great potential to use as a novel sustained release system for breviscapine.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Zhang J, Li X, Zhang W . The advance in studies on chemical component and pharmacology of Erigeron breviscapus. J Pharm Pract 2002; 20: 103–7.
He W, Zeng FD . Effect of breviscapine on Ischemic cerebrovascular disease and its clinical investigation. Chin J Clin Pharmacol 2002; 6: 458–461.
Cui J, Wu S . The advance on the research of breviscapine. Nat Prod Res Dev 2003; 15: 255–8.
Liu X, Yang L, Wang X, Xu H, Zhao H . Determination of scutellarin in rat plasma by HPLC and its pharmacokinetics. Chin J Pharm 2007; 38: 525.
Zhong H, Deng Y, Wang X, Yang B . Multivesicular liposome formulation for the sustained delivery of breviscapine. Int J Pharm 2005; 301: 15–24.
Lv W, Guo J, Li J, Wang X, Li J, Ping Q . Preparation and pharmacokinetics in rabbits of breviscapine unilamellar vesicles. Drug Dev Ind Pharm 2006; 32: 309–14.
Liu M, Li H, Luo G, Liu Q, Wang Y . Pharmacokinetics and biodistribution of surface modification polymeric nanoparticles. Arch Pharm Res 2008; 31: 547–54.
Wissing S, Kayser O, Müller R . Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliver Rev 2004; 56: 1257–72.
Müller RH, Mäder K, Gohla S . Solid lipid nanoparticles (SLN) for controlled drug delivery — a review of the state of the art. Eur J Pharm Biopharm 2000; 50: 161–77.
Cevc G, Vierl U . Nanotechnology and the transdermal route: A state of the art review and critical appraisal. J Control Release 2010; 141: 277–99.
Angst MS, Drover DR . Pharmacology of drugs formulated with DepoFoam: a sustained release drug delivery system for parenteral administration using multivesicular liposome technology. Clin pharmacokinet 2006; 45: 1153–76.
Li X, Nie S, Kong J, Li N, Ju C, Pan W . A controlled-release ocular delivery system for ibuprofen b ased on nanostructured lipid carriers. Int J Pharm 2008; 363: 177–82.
Muller RH, Keck CM . Challenges and solutions for the delivery of biotech drugs — a review of drug nanocrystal technology and lipid nanoparticles. J biotechnol 2004; 113: 151–70.
Müller R, Olbrich C . Drug-delivery vehicle for the controlled administration of an active agent, produced from lipid matrix-medicament conjugates. PCT Int Appl WO 2000 ; 2000067800.
Joshi MD, Müller RH . Lipid nanoparticles for parenteral delivery of actives. Eur J Pharm Biopharm 2009; 71: 161–72.
Smith RM, Alberty RA . The apparent stability constants of Ionic complexes of various adenosine phosphates with divalent cations1, 2. J Am Chem Soc 1956; 78: 2376–80.
Bieske E, Maier J . Spectroscopic studies of ionic complexes and clusters. Chem Rev 1993; 93: 2603–21.
Polfer NC, Oomens J . Vibrational spectroscopy of bare and solvated ionic complexes of biological relevance. Mass Spectrom Rev 2009; 28: 468–94.
Tominaga Y, Kubo T, Kaya K, Hosoya K . Effective recognition on the surface of a polymer prepared by molecular imprinting using ionic complex. Macromolecules 2009; 42: 2911–15.
Balapanuru J, Yang JX, Xiao S, Bao Q, Jahan M, Polavarapu L, et al. A graphene oxide-organic dye ionic complex with DNA — Sensing and optical-limiting properties. Angewandte Chemie 2010; 122: 6699–703.
Kim YJ, Chae SY, Jin CH, Sivasubramanian M, Son S, Choi KY, et al. Ionic complex systems based on hyaluronic acid and PEGylated TNF-related apoptosis-inducing ligand for treatment of rheumatoid arthritis. Biomaterials 2010; 31: 9057–64.
Pino T, Boudin N, Bréchignac P . Electronic absorption spectrum of cold naphthalene cation in the gas phase by photodissociation of its van der Waals complexes. J Chem Phys 1999; 111: 7337.
Lv W, Guo J, Li J, Huang L, Ping Q . Distribution of liposomal breviscapine in brain following intravenous injection in rats. Int J Pharm 2005; 306: 99–106.
Pardeike J, Hommoss A, Müller RH . Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm 2009; 366: 170–84.
Fang KT, Wang Y, Bentler PM . Some applications of number-theoretic methods in statistics. Stat Sci 1994; 9: 416–28.
Hedayat AS, Sloane NJA, Stufken J . Orthogonal arrays: theory and applications. Springer; 1999.
Peng Q, Zhang ZR, Sun X, Zuo J, Zhao D, Gong T . Mechanisms of phospholipid complex loaded nanoparticles enhancing the oral bioavailability. Mol Pharm 2010; 7: 565–75.
Xiong F, Wang H, Cheng J, Zhu J . Determination of scutellarin in mouse plasma and different tissues by high-performance liquid chromatography. J Chromatogr B 2006; 835: 114–8.
Guo Y, Liu X, Sun X, Zhang Q, Gong T, Zhang Z . Mannosylated lipid nano-emulsions loaded with lycorine-oleic acid ionic complex for tumor cell-specific delivery. Theranostics 2012; 2:1104–14.
Choi SH, Park TG . Hydrophobic ion pair formation between leuprolide and sodium oleate for sustained release from biodegradable polymeric microspheres. Int J Pharm 2000; 203: 193–202.
Galeano NF, Milne R, Marcel YL, Walsh MT, Levy E, Ngu'yen TD, et al. Apoprotein B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size. J Biol Chem 1994; 269: 511–9.
Hu FQ, Jiang SP, Du YZ, Yuan H, Ye YQ, Zeng S . Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloid Surface B 2005; 45: 167–73.
Zhang X, Pan W, Gan L, Zhu C, Gan Y, Nie S . Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying. Chem Pharm Bull 2008; 56: 1645–50.
Lee YL, Yang YC, Shen YJ . Monolayer characteristics of mixed octadecylamine and stearic acid at the air/water interface. J Phys Chem B 2005; 109: 4662–7.
Ralston A, Hoerr CW, Hoffman EJ . Studies on high molecular weight aliphatic amines and their salts. VII. The Systems Octylamine-, Dodecylamine-, and octadecylamine-water. J Am Chem Soc 1942; 64: 1516–23.
Yu B, Zhang Y, Zheng W, Fan C, Chen T . Positive surface charge enhances selective cellular uptake and anticancer efficacy of selenium nanoparticles. Inorg Chem 2012; 51:8956–63.
Ritger PL, Peppas NA . A simple equation for description of solute release I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release 1987; 5: 23–36.
Bisrat M, Nyström C . Physicochemical aspects of drug release. VIII. The relation between particle size and surface specific dissolution rate in agitated suspensions. Int J Pharm 1988; 47: 223–31.
Hixon AW, Crowel JH . Dependence of reaction velocity upon surface and agitation. I-Theoretical considerations. Ind Eng Chem 1931; 23: 923–31.
Joshi M, Pathak S, Sharma S, Patravale V . Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject. Int J Pharm 2008; 364: 119–26.
O'Leary KA, Day AJ, Needs PW, Mellon FA, O'Brien NM, Williamson G . Metabolism of quercetin-7- and quercetin-3-glucuronides by an in vitro hepatic model: the role of human β-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism. Biochem Pharmacol 2003; 65: 479–91.
Zhang JL, Che QM, Li SZ, Zhou TH . Study on metabolism of scutellarin in rats by HPLC-MS and HPLC-NMR. J Asian Nat ProdP Res 2003; 5: 249–56.
Chen X, Cui L, Duan X, Ma B, Zhong D . Pharmacokinetics and metabolism of the flavonoid scutellarin in humans after a single oral administration. Drug Metab Dispos 2006; 34: 1345–52.
Nguyen MK, Huynh CT, Gao GH, Kim JH, Chae SY, Lee KC, et al. Biodegradable oligo (amidoamine/β-amino ester) hydrogels for controlled insulin delivery. Soft Matter 2011; 7: 2994–3001.
Zhang X, Sun X, Li J, Zhang X, Gong T, Zhang Z . Lipid nanoemulsions loaded with doxorubicin-oleic acid ionic complex: characterization, in vitro and in vivo studies. Pharmazie 2011; 66: 496–505.
Zhuang CY, Li N, Wang M, Zhang XN, Pan WS, Peng JJ, et al. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability. Int J Pharm 2010; 394: 179–85.
Acknowledgements
This work was supported by grants from the National Basic Research Program of China (973 program, No 2013CB932504), the National S&T Major Project of China (Grant No 2012ZX09304004) and the National Natural Science Foundation of China (No 81273443).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, M., Zheng, Y., Shan, Fy. et al. Development of ionic-complex-based nanostructured lipid carriers to improve the pharmacokinetic profiles of breviscapine. Acta Pharmacol Sin 34, 1108–1115 (2013). https://doi.org/10.1038/aps.2013.43
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2013.43
Keywords
This article is cited by
-
Biocompatible Cationic Lipoamino Acids as Counterions for Oral Administration of API-Ionic Liquids
Pharmaceutical Research (2022)
-
Rifampicin Loaded Mannosylated Cationic Nanostructured Lipid Carriers for Alveolar Macrophage-specific Delivery
Pharmaceutical Research (2015)
